FEBS Open Bio

译名:FEBS开放生物

SCIEJCR Q3

1-3

2026

影响因子区间

平台估算

投稿周期

3%

2025

中国作者发文占比

1969 USD

费用说明

收费

期刊简介:FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal's peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.FEBS Open Bio is owned by the Federation of European Biochemical Societies (FEBS), a not-for-profit organization, and is published on behalf of FEBS by FEBS Press and Wiley. Any income from the journal will be used to support scientists through fellowships, courses, travel grants, prizes and other FEBS initiatives.

【译文】FEBS Open Bio是一本仅在线开放获取的期刊,专注于快速发表关于健康和疾病领域的分子和细胞生命科学的研究文章。该期刊的同行评审过程侧重于论文的技术严谨性,将对其影响和重要性的评估留给科学界。FEBS Open Bio由非营利组织欧洲生化学会(FEBS)拥有,并由FEBS Press和Wiley代为出版。期刊的任何收入都将用于通过奖学金、课程、旅行补助、奖项和其他FEBS倡议来支持科学家。

出版社
Wiley
语言
English
学科
生物学
ISSN
2211-5463
eISSN
2211-5463
出版频率
年刊
创刊年份
2014
投稿网址
https://mc.manuscriptcentral.com/febsopen
最近更新
2026-04-02 18:16:40
FEBS Open Bio

指标当前值近三年趋势
JCR分区Q3
暂无
影响因子区间1-3
暂无